Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
ONB$25.02-0.02(-0.06%)Old National Chairman and CEO Jim Ryan Named Chair-Elect of the American Bankers Association[2:07:00 PM ET]BCRD$5.530.00(0.00%)BlueOne Technologies Announces Enhance Global Remittance Platform[2:04:41 PM ET]CWK$12.14+0.24(+2.02%)Cushman & Wakefield Arranges $130 Million Sale of Seasons of Traverse Mountain in Lehi, Utah[2:01:00 PM ET]CTAS$214.12-11.81(-5.23%)Cintas Corporation Announces Quarterly Cash Dividend[2:00:00 PM ET]QNBC$46.45+0.45(+0.98%)QNB Corp. Reports Third Quarter 2026 Results[1:59:23 PM ET]CNXC$31.26-0.75(-2.36%)Concentrix Breaks the Language Barrier with Live Voice Translation[1:55:00 PM ET]CEG$258.61+6.13(+2.43%)Constellation Secures Conditional DOE Loan Commitment of up to $5 Billion to Expand Nuclear Output[1:35:00 PM ET]TXTM$0.01+0.00(+4.76%)Canouse Announces Unsatisfied Federal Judgment Against Protext Mobility, Inc. (OTC: TXTM)[1:35:00 PM ET]ARAI$0.11-0.00(-1.70%)Arrive AI Installs First Arrive Point(TM) Residential Unit[1:23:00 PM ET]

PODD · NASDAQ

Insulet Corporation

$149.95 +0.73 (+0.49%)

Company overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ
Market cap
$10.4B
Employees
5,400
Headquarters
Acton, MA
Website
insulet.com
CEO
Ashley A. McEvoy
Listed
May 15, 2007
P/E
34.80
Dividend yield
0.00%

Company financials

Revenue
$2.9B
Gross profit
$2.1B
Operating income
$507M
EBITDA
$562M
Net income
$303M
EPS
$4.31
Total assets
$3B
Total debt
$948M
Gross margin
71.01%
Net margin
10.44%
Earnings yield
2.87%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

123.69142.01160.34178.66196.98
PODD 1D NASDAQ O149.01H150.74L146.71C149.26+0.25 (+0.17%)Vol1.53M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
PODDInsulet Corporation Legal Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Insulet Corporation (PODD) And Encourages Investors to Reach Out ACCESS Newswire
PODDInsulet Corporation Press release Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly GlobeNewswire
PODDInsulet Corporation Legal Bronstein, Gewirtz & Grossman (PODD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation ACCESS Newswire
PODDInsulet Corporation Stock news Insulet Corporation $PODD Shares Sold by Curated Wealth Partners LLC Defense World
PODDInsulet Corporation Stock news Here's Why Insulet (PODD) is a Strong Growth Stock Zacks Investment Research
PODDInsulet Corporation Legal Bronstein, Gewirtz & Grossman, LLC Is Investigating Bronstein, Gewirtz & Grossman (PODD) And Encourages Investors to Connect ACCESS Newswire
PODDInsulet Corporation Press release Insulet Announces Omnipod Discover Now Available in U.S. Business Wire
PODDInsulet Corporation Press release Important Notice to Long-Term Shareholders of Beta Bionics, GlobeNewswire
PODDInsulet Corporation Press release Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026 Business Wire
PODDInsulet Corporation Press release Important Notice to Long-Term Shareholders of Doximity, GlobeNewswire
PODDInsulet Corporation Stock news Why Insulet (PODD) is a Top Growth Stock for the Long-Term Zacks Investment Research
PODDInsulet Corporation Stock news Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum MarketBeat
PODDInsulet Corporation Stock news Insulet Corporation (PODD) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript Seeking Alpha
PODDInsulet Corporation Stock news Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum Business Wire
PODDInsulet Corporation Press release Important Notice to Long-Term Shareholders of FuelCell GlobeNewswire
PODDInsulet Corporation Stock news Insulet Corporation $PODD Stock Position Raised by Amundi Defense World
PODDInsulet Corporation Stock news Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Seeking Alpha
PODDInsulet Corporation Stock news Here's Why Insulet (PODD) is a Strong Growth Stock Zacks Investment Research
PODDInsulet Corporation Stock news Is it Prudent to Retain Insulet Stock in Your Portfolio for Now? Zacks Investment Research
PODDInsulet Corporation Stock news Insulet (PODD) is a Top-Ranked Value Stock: Should You Buy? Zacks Investment Research
See more
FAQ

Questions about Insulet Corporation

What does Insulet Corporation do?
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
What is PODD's market cap?
Insulet Corporation (PODD) is a listed stock with a live quote. The latest market cap on this page is $10.4B.
Where is Insulet Corporation headquartered?
Insulet Corporation is headquartered in Acton, MA.
How do I get PODD news from the API?
Call GET /v1/news?tickers=PODD. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does PODD news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for PODD, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the PODD price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs